Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
132M
-
Number of holders
-
104
-
Total 13F shares, excl. options
-
31.8M
-
Shares change
-
-615K
-
Total reported value, excl. options
-
$97M
-
Value change
-
-$17.6M
-
Put/Call ratio
-
0.7
-
Number of buys
-
39
-
Number of sells
-
-31
-
Price
-
$3.05
Significant Holders of RAPT Therapeutics, Inc. - Common Stock (RAPT) as of Q2 2024
136 filings reported holding RAPT - RAPT Therapeutics, Inc. - Common Stock as of Q2 2024.
RAPT Therapeutics, Inc. - Common Stock (RAPT) has 104 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 31.8M shares
of 132M outstanding shares and own 24.09% of the company stock.
Largest 10 shareholders include FMR LLC (5.24M shares), VANGUARD GROUP INC (3.11M shares), Column Group LLC (2.68M shares), BlackRock Inc. (2.44M shares), KINGDON CAPITAL MANAGEMENT, L.L.C. (1.73M shares), MORGAN STANLEY (1.18M shares), MILLENNIUM MANAGEMENT LLC (1.02M shares), DEUTSCHE BANK AG\ (933K shares), D. E. Shaw & Co., Inc. (907K shares), and FEDERATED HERMES, INC. (796K shares).
This table shows the top 104 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.